CN101496908A - Pearl powder artificial bone supporting material with multi-stage micro-nano structure and technique for producing the same - Google Patents

Pearl powder artificial bone supporting material with multi-stage micro-nano structure and technique for producing the same Download PDF

Info

Publication number
CN101496908A
CN101496908A CNA2009100963338A CN200910096333A CN101496908A CN 101496908 A CN101496908 A CN 101496908A CN A2009100963338 A CNA2009100963338 A CN A2009100963338A CN 200910096333 A CN200910096333 A CN 200910096333A CN 101496908 A CN101496908 A CN 101496908A
Authority
CN
China
Prior art keywords
plga
pearl powder
pla
scaffold
artificial bone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2009100963338A
Other languages
Chinese (zh)
Other versions
CN101496908B (en
Inventor
徐铭恩
索海瑞
王秋君
李艳蕾
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hangzhou Giantlok Fly Biological Polytron Technologies Inc
Original Assignee
Hangzhou Electronic Science and Technology University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hangzhou Electronic Science and Technology University filed Critical Hangzhou Electronic Science and Technology University
Priority to CN2009100963338A priority Critical patent/CN101496908B/en
Publication of CN101496908A publication Critical patent/CN101496908A/en
Application granted granted Critical
Publication of CN101496908B publication Critical patent/CN101496908B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Materials For Medical Uses (AREA)

Abstract

本发明涉及一种新的用于骨修复的生物支架材料及其制备方法。将质量比为1∶1-10∶1的PLGA和PLA溶解于氯仿、二甲基亚砜、1,4-二氧六环或1,4-二氧六环与超纯水的混合液体,然后按照PLGA/PLA混合物∶珍珠粉(质量比)为1∶1-10∶1的比例加入经部分脱蛋白或完全脱蛋白处理珍珠粉制成成形浆料。通过3D软件设计具有高孔隙率和连通率的三维支架,然后利用低温快速成型系统使三维支架成型得到具有微孔结构的支架。根据上述方法制备的人工骨生物支架材料,其宏观结构为具有100-500μm孔径通道,微结构为具有10-20μm微孔的三维支架结构,其中微孔壁弥散分布着微米级珍珠粉。孔隙率为60%-90%,大孔结构的X、Y、Z轴三个方向贯通,具有100%的贯通率。The invention relates to a new bio-scaffold material for bone repair and a preparation method thereof. Dissolve PLGA and PLA with a mass ratio of 1:1-10:1 in chloroform, dimethyl sulfoxide, 1,4-dioxane or a mixed liquid of 1,4-dioxane and ultrapure water, Then according to the ratio of PLGA/PLA mixture: pearl powder (mass ratio) of 1:1-10:1, pearl powder treated with partial deproteinization or complete deproteinization is added to form a forming slurry. A three-dimensional scaffold with high porosity and connectivity is designed by 3D software, and then a low-temperature rapid prototyping system is used to shape the three-dimensional scaffold to obtain a scaffold with a microporous structure. The artificial bone bio-scaffold material prepared according to the above-mentioned method has a macrostructure of a channel with a pore diameter of 100-500 μm, and a microstructure of a three-dimensional scaffold structure with a micropore of 10-20 μm, wherein micron pearl powder is dispersedly distributed on the wall of the micropore. The porosity is 60%-90%, and the X, Y, and Z axes of the macroporous structure penetrate in three directions, with a penetration rate of 100%.

Description

一种具有多级微纳结构的珍珠粉人工骨支架材料及其生产工艺 A kind of pearl powder artificial bone scaffold material with multi-level micro-nano structure and its production process

技术领域 technical field

本发明属于生物医用材料技术领域,具体的说,涉及一种新的用于骨修复的生物支架材料及其制备方法。The invention belongs to the technical field of biomedical materials, and in particular relates to a new bio-scaffold material for bone repair and a preparation method thereof.

发明背景Background of the invention

目前在全球范围内,对具有良好生理功能无排异反应,用于骨缺损修复的人工骨组织,具有迫切和巨大的市场需求。在人工骨制造领域,国外研究机构和企业近年来投入了大量资源,并取得了一系列研究成果,一些用于缺损修复的人工骨材料开始进入临床应用。与此同时,骨支架材料的核心问题如生物相容性、骨诱导性、孔隙率和机械强度等依旧存在很多问题需要解决。At present, there is an urgent and huge market demand for artificial bone tissue with good physiological functions and no rejection for bone defect repair in the world. In the field of artificial bone manufacturing, foreign research institutions and enterprises have invested a lot of resources in recent years and achieved a series of research results. Some artificial bone materials for defect repair have begun to enter clinical applications. At the same time, there are still many problems to be solved in the core issues of bone scaffold materials such as biocompatibility, osteoinductivity, porosity, and mechanical strength.

珍珠粉是一种理想的天然成骨材料,具有生物相容性、诱导性好的特点,具有广阔的应用前景。珍珠层的理化性质及生物学特性与骨组织非常接近,研究显示珍珠层与骨之间遗传学上具有亲缘关系,使得珍珠层具有良好的生物相容性(Westbroek P,et al;1998,392(6679):861-2)。而且珍珠层植入物在体内可被溶解、吸收,具优良的生物降解特性。在体内将珍珠层注入椎体骨缺失模型中,可观察到珍珠层逐渐降解,骨缺损处形成新的成熟骨小梁,骨小梁表面被线性排列的成骨细胞类骨质覆盖,珍珠层与新骨紧密结合,显示珍珠层在体内能刺激成骨细胞分化和新骨形成(Lamghari M,et al;Biomaterials.2001,22(6):555-62)。对机理的研究显示,珍珠层降解时释放钙离子,使局部钙离子浓度增高,形成成骨矿化的先决条件。Miyamoto H等(Proc.Natl.Acad.Sci.U S A,1996,93(18):9657-60)认为珍珠层基质蛋白N66的的碳酸酐酶样结构域可催化HCO3-形成,参与碳酸钙结晶的形成。而Samata T等(FEBS Lett,1999,462(1-2):225-9)发现基质蛋白N16、N66和N4重复区能形成类似甘氨酸环样的结构,有结合Ca2+的能力,调控结晶形成。珍珠层基质还可产生一些化学信号,具有激活成骨细胞的能力(Almeida MJ,et al;J.Biomed.Mater.Res.2001,57(2):306-12)。Lopez等经多年试验和研究认为珍珠母有机成分中含有类似于BMPs(骨形态发生蛋白)的信号分子,进入体内后,可以扩散到骨髓中,继而对成骨基质细胞产生一种趋化作用,激活骨髓中的生骨细胞,使其分化,产生成骨细胞,最终诱导新骨形成。张恩等(矿物学报,2008,2:112-116)采用SEM和HRTEM技术发现珍珠质层是由有机质胶结的文石组成片状晶层,并与有机质层交互平行叠置。同时,在棱柱状和片状文石晶体的截面上,含有大量纳米级的圆形、椭圆形等形状的有机质、气液包裹体或孔洞。Pearl powder is an ideal natural bone-forming material, which has the characteristics of biocompatibility and good inductivity, and has broad application prospects. The physical and chemical properties and biological characteristics of nacre are very close to those of bone tissue. Studies have shown that there is a genetic relationship between nacre and bone, which makes nacre have good biocompatibility (Westbroek P, et al; 1998, 392 (6679):861-2). Moreover, the nacre implant can be dissolved and absorbed in the body, and has excellent biodegradation characteristics. Nacre was injected into the vertebral bone loss model in vivo, and it was observed that the nacre gradually degraded, and new mature bone trabeculae formed at the bone defect. Tightly combined with new bone, it was shown that nacre can stimulate osteoblast differentiation and new bone formation in vivo (Lamghari M, et al; Biomaterials. 2001, 22(6):555-62). The study of the mechanism shows that when the nacre degrades, calcium ions are released, which increases the local calcium ion concentration and forms the prerequisite for osteogenic mineralization. Miyamoto H et al. (Proc.Natl.Acad.Sci.USA, 1996,93(18):9657-60) think that the carbonic anhydrase-like domain of nacre matrix protein N66 can catalyze HCO3-formation, participate in the crystallization of calcium carbonate form. And Samata T et al. (FEBS Lett, 1999, 462(1-2): 225-9) found that the N16, N66 and N4 repeat regions of the matrix protein can form a structure similar to a glycine ring, which has the ability to bind Ca 2+ and regulate crystallization form. Nacre matrix can also produce some chemical signals and has the ability to activate osteoblasts (Almeida MJ, et al; J. Biomed. Mater. Res. 2001, 57(2): 306-12). After years of experiments and research, Lopez et al. believe that the organic components of mother of pearl contain signal molecules similar to BMPs (bone morphogenetic proteins). After entering the body, they can diffuse into the bone marrow, and then produce a chemotactic effect on osteogenic stromal cells. Activate the osteogenic cells in the bone marrow, make them differentiate, produce osteoblasts, and finally induce new bone formation. Zhang En et al. (Acta Mineralogical Sinica, 2008, 2: 112-116) used SEM and HRTEM techniques to find that the nacre layer is composed of aragonite cemented with organic matter, which is composed of flaky crystal layers, and overlaps with the organic matter layer in parallel. At the same time, on the cross-section of prism-shaped and plate-shaped aragonite crystals, there are a large number of nano-scale circular, elliptical and other shapes of organic matter, gas-liquid inclusions or holes.

珍珠粉作为人工骨材料,尚需解决的关键问题的是材料可塑性和成型性差,不易形成具有很好孔隙率和联通率的结构。而常用的化学发泡、高温烧结等方法对珍珠粉的成型效果差,还容易导致使珍珠粉中具有骨诱导作用的活性成分失去活性,因此选择合适而先进的多孔支架制造工艺,包括辅料和成型方法的选择,是珍珠粉材料能否有效应用于骨修复再生的关键问题。Pearl powder is used as an artificial bone material, but the key problem to be solved is that the material has poor plasticity and formability, and it is difficult to form a structure with good porosity and connectivity. However, the commonly used methods such as chemical foaming and high-temperature sintering have poor molding effects on pearl powder, and can easily lead to the inactivation of the active ingredients in pearl powder that have osteoinductive effects. Therefore, a suitable and advanced porous scaffold manufacturing process is selected, including auxiliary materials and The choice of molding method is the key issue whether the pearl powder material can be effectively used in bone repair and regeneration.

发明内容 Contents of the invention

本发明的一个目的是提供一种新的用于制备人工骨生物支架材料的组合物。One object of the present invention is to provide a new composition for preparing artificial bone bio-scaffold materials.

本发明的另一个目的是提供一种人工骨生物支架材料,该材料具有高孔隙率和高连通率,同时具有较好的机械强度。Another object of the present invention is to provide a bioscaffold material for artificial bone, which has high porosity and high connectivity and good mechanical strength.

本发明的另一个目的是提供一种制备上述人工骨生物支架材料的方法。Another object of the present invention is to provide a method for preparing the above artificial bone bio-scaffold material.

珍珠粉作为人工骨材料,尚需解决的关键问题是材料可塑性和成型性差,不易形成具有很好孔隙率和连通率的结构。而聚乳酸(Polylactic acid,PLA)是由丙交酯(LA)在一定条件下聚合而成的可降解高分子材料,聚乳酸/乙醇酸共聚物(polylactide-co-glycolide,PLGA)则是由丙交酯(LA)和乙交酯(GA)在一定条件下聚合而成的可降解高分子材料。这两种材料具有可塑性高,降解快,易成形的特点,具有良好的生物相容性和骨传导性能,能进行完全的生物降解,其降解产物可以进入人体的代谢途径,最终转化为二氧化碳和水,这两种材料已经FDA批准广泛应用于注射用微胶囊、微球及埋植剂等缓释制剂的辅料,同时可用作组织工程细胞培养的多孔支架。As an artificial bone material, pearl powder still needs to be solved. The key problem is that the material has poor plasticity and formability, and it is difficult to form a structure with good porosity and connectivity. Polylactic acid (PLA) is a degradable polymer material formed by polymerization of lactide (LA) under certain conditions, and polylactic acid/glycolic acid copolymer (polylactide-co-glycolide, PLGA) is made of Lactide (LA) and glycolide (GA) are polymerized degradable polymer materials under certain conditions. These two materials have the characteristics of high plasticity, fast degradation, easy forming, good biocompatibility and bone conduction performance, and can be completely biodegraded, and their degradation products can enter the metabolic pathway of the human body, and finally converted into carbon dioxide and Water, these two materials have been approved by the FDA and are widely used as excipients for sustained-release preparations such as injection microcapsules, microspheres and implants, and can also be used as porous scaffolds for tissue engineering cell culture.

发明人经大量实验发现,以生物相容的高分子材料PLA和PLGA为成型辅料与珍珠层粉复合,可以弥补其不易成形之不足,同时可调节成型支架的孔隙率、孔径和机械强度。The inventors have found through a large number of experiments that using biocompatible polymer materials PLA and PLGA as molding auxiliary materials and nacre powder can make up for the lack of difficulty in molding, and at the same time adjust the porosity, pore size, and mechanical strength of the molding scaffold.

因此,发明人制备了一种新型组合物,该组合物包括PLGA,PLA和珍珠粉,所述组合物中PLGA:PLA(质量比)为1:1-10:1,优选3:1-5:1;PLGA/PLA混合物:珍珠粉(质量比)为1:1-10:1,优选2:1-4:1,最优选为7:3;所述的珍珠粉粒度在2000目以下,优选直径为1-10微米,更优选为3-6微米。Therefore, the contriver has prepared a kind of novel composition, and this composition comprises PLGA, PLA and pearl powder, and in said composition, PLGA:PLA (mass ratio) is 1:1-10:1, preferably 3:1-5 : 1; PLGA/PLA mixture: pearl powder (mass ratio) is 1:1-10:1, preferably 2:1-4:1, most preferably 7:3; described pearl powder particle size is below 2000 orders, Preferably the diameter is 1-10 microns, more preferably 3-6 microns.

上述组合物中,PLGA:PLA(质量比)为1:1-10:1,优选3:1-5:1。所述的PLGA中LA/GA的比例为90/10、80/20、75/25、60/40、或50/50,优选LA/GA为50/50。在该组合物中,PLA的加入是为了调节最后制成的人工骨生物支架材料的机械强度,增加其比例可以改善支架结构的稳定性和力学性能要求。In the above composition, PLGA:PLA (mass ratio) is 1:1-10:1, preferably 3:1-5:1. The ratio of LA/GA in the PLGA is 90/10, 80/20, 75/25, 60/40, or 50/50, preferably LA/GA is 50/50. In the composition, PLA is added to adjust the mechanical strength of the final artificial bone bio-scaffold material, and increasing its ratio can improve the stability and mechanical performance requirements of the scaffold structure.

将上述比例的PLGA、PLA溶解于有机溶剂,有机溶剂可选择1,4-二氧六环或1,4-二氧六环与超纯水的混合液体,优选1,4-二氧六环与超纯水的混合液体,混合液体中超纯水约占总体积的1%-20%,优选为5%-10%。将PLGA、PLA溶解于有机溶剂后,然后按照PLGA/PLA混合物:珍珠粉(质量比)以1:1-10:1,优选2:1-4:1,最优选为7:3的比例加入珍珠粉成为制备人工骨生物支架材料的成形浆料。其中,所述的珍珠粉粒度在2000目以下,优选直径为1-10微米,更优选为3-6微米。为提高珍珠粉的生物相容性,降低免疫原性,上述珍珠粉优选部分去蛋白珍珠粉或完全去蛋白的珍珠粉。经过特殊的部分脱蛋白处理后珍珠粉的生物相容性可进一步提高,同时保留具有骨诱导活性的生物因子。完全脱蛋白的珍珠粉,则保留100nm级别的规则片层间隙和圆形孔洞结构,该结构有助于营养物质扩散、成骨细胞增殖和骨的生成。Dissolve the PLGA and PLA in the above ratio in an organic solvent. The organic solvent can be 1,4-dioxane or a mixed liquid of 1,4-dioxane and ultrapure water, preferably 1,4-dioxane The mixed liquid with ultrapure water, the ultrapure water in the mixed liquid accounts for about 1%-20% of the total volume, preferably 5%-10%. After dissolving PLGA and PLA in an organic solvent, add PLGA/PLA mixture: pearl powder (mass ratio) at a ratio of 1:1-10:1, preferably 2:1-4:1, most preferably 7:3 The pearl powder becomes the forming slurry for preparing the artificial bone bio-scaffold material. Wherein, the particle size of the pearl powder is below 2000 mesh, preferably 1-10 microns in diameter, more preferably 3-6 microns in diameter. In order to improve the biocompatibility of the pearl powder and reduce the immunogenicity, the above-mentioned pearl powder is preferably partially deproteinized pearl powder or completely deproteinized pearl powder. After special partial deproteinization treatment, the biocompatibility of pearl powder can be further improved, while retaining biological factors with osteoinductive activity. Completely deproteinized pearl powder retains 100nm-level regular lamellar gaps and circular hole structures, which are conducive to the diffusion of nutrients, proliferation of osteoblasts, and bone formation.

上述成形浆料可用于制备人工骨生物支架材料,在低温环境中浆料中均匀的聚酯溶液发生固—液相分离/液—液相分离,生成溶剂结晶和富聚酯相结晶,然后在更低的温度下分离的两相均凝固成固体。真空冷冻干燥环境中有机溶剂迅速挥发,最终形成含有PLGA、PLA和珍珠粉的组合物,所述组合物中PLGA:PLA(质量比)为1:1-10:1,优选3:1-5:1;PLGA/PLA混合物:珍珠粉(质量比)为1:1-10:1,优选2:1-4:1,最优选为7:3;所述的珍珠粉粒度在2000目以下,优选直径为1-10微米,更优选为3-6微米。The above-mentioned forming slurry can be used to prepare artificial bone bio-scaffold materials. In the low-temperature environment, the uniform polyester solution in the slurry undergoes solid-liquid phase separation/liquid-liquid phase separation to generate solvent crystallization and polyester-rich phase crystallization, and then Both phases that separate at lower temperatures solidify into solids. In the vacuum freeze-drying environment, the organic solvent volatilizes rapidly, and finally forms a composition containing PLGA, PLA and pearl powder. In the composition, PLGA:PLA (mass ratio) is 1:1-10:1, preferably 3:1-5 : 1; PLGA/PLA mixture: pearl powder (mass ratio) is 1:1-10:1, preferably 2:1-4:1, most preferably 7:3; described pearl powder particle size is below 2000 orders, Preferably the diameter is 1-10 microns, more preferably 3-6 microns.

在骨修复中,临床需要最为迫切的是具有较大体积、有特定外型、结构复杂的骨支架材料。良好的孔隙率是组织工程骨快速血管化、并被自体骨替代的基础。对于大段骨支架材料制造,普通的燃烧、发泡等方法,在孔隙率和力学性能上都不能满足要求,而快速成型(RPM)制造技术是目前最具前景的选择。由于快速成型技术对支架结构的可控性,使得对支架结构的设计成为可能,而结构不但影响人工骨的孔隙率、连通率、血管化,也决定了材料的力学性能。美国MIT和普林斯顿大学的研究者,近年成功利用快速成型设备,制造出了人工骨料,目前产品已完成动物实验,进入临床前审批(Sherwood JK,et al;Biomaterials,2002,23(24):4739-51)。德国Seitz H等(J.Biomed.Mater.Res.B.Appl.Biomater;2005,74(2):7828)用3D打印技术,成功制造了内部具有复杂通道和孔隙的骨材料,材料呈现良好的机械强度,目前开始进入了产业化开发。In bone repair, the most urgent clinical needs are bone scaffold materials with large volume, specific shape and complex structure. Good porosity is the basis for rapid vascularization of tissue-engineered bone and its replacement by autologous bone. For the manufacture of large bone scaffold materials, common methods such as combustion and foaming cannot meet the requirements in terms of porosity and mechanical properties, and rapid prototyping (RPM) manufacturing technology is currently the most promising option. Due to the controllability of the rapid prototyping technology to the scaffold structure, it is possible to design the scaffold structure, and the structure not only affects the porosity, connectivity, and vascularization of the artificial bone, but also determines the mechanical properties of the material. Researchers from MIT and Princeton University in the United States have successfully used rapid prototyping equipment to manufacture artificial aggregates in recent years. The current product has completed animal experiments and entered preclinical approval (Sherwood JK, et al; Biomaterials, 2002, 23(24): 4739-51). German Seitz H et al. (J.Biomed.Mater.Res.B.Appl.Biomater; 2005, 74(2): 7828) used 3D printing technology to successfully manufacture bone materials with complex channels and pores inside, and the materials showed good Mechanical strength has now entered into industrial development.

利用前述的成形浆料,采用用低温快速成型的方法可以构建具有高孔隙率和连通率的人工骨生物支架材料。本发明提出的制备上述用于骨修复的生物复合材料支架的方法,包括以下步骤:Utilizing the above-mentioned forming slurry, the artificial bone bio-scaffold material with high porosity and connectivity can be constructed by adopting the low-temperature rapid prototyping method. The method for preparing the above-mentioned biocomposite scaffold for bone repair proposed by the present invention comprises the following steps:

(1)、制备部分脱蛋白珍珠粉或完全脱蛋白珍珠粉;(1), prepare partial deproteinized pearl powder or completely deproteinized pearl powder;

(2)、制备含PLGA,PLA和珍珠粉的浆料;(2), preparation contains PLGA, the slurry of PLA and pearl powder;

(3)、通过3D软件设计具有高孔隙率和连通率的三维支架;(3) Design a three-dimensional support with high porosity and connectivity through 3D software;

(4)、利用低温快速成型系统使三维支架成型。(4) Using a low-temperature rapid prototyping system to shape the three-dimensional scaffold.

在步骤(1)中,取粒度在2000目以下的微米级珍珠粉干燥,然后用振动筛对其进行筛分以获得优选直径为1-10微米、更优选为3-6微米的珍珠粉,随后对珍珠粉进行脱脂,表面脱钙,部分脱蛋白或完全脱蛋白处理,干燥后消毒备用。In step (1), the micron pearl powder with particle size below 2000 mesh is dried, and then sieved with a vibrating sieve to obtain pearl powder with a preferred diameter of 1-10 microns, more preferably 3-6 microns, Then the pearl powder is degreased, decalcified on the surface, partially deproteinized or completely deproteinized, dried and sterilized for use.

在步骤(2)中,将质量比为1:1-10:1(优选3:1-5:1)的PLGA和PLA溶解于有机溶剂,所述有机溶剂选自氯仿、二甲基亚砜、1,4-二氧六环或1,4-二氧六环与超纯水的混合液体,优选1,4-二氧六环与超纯水的混合液体,混合液体中超纯水约占总体积的1%-20%,优选为5%-10%。将PLGA、PLA溶解于有机溶剂后,然后按照一定的比例加入步骤(1)中的珍珠粉制成成形浆料备用,所述的PLGA/PLA混合物:珍珠粉(质量比)为1:1-10:1,优选2:1-4:1,最优选为7:3;In step (2), PLGA and PLA with a mass ratio of 1:1-10:1 (preferably 3:1-5:1) are dissolved in an organic solvent selected from the group consisting of chloroform, dimethylsulfoxide , 1,4-dioxane or the mixed liquid of 1,4-dioxane and ultrapure water, preferably the mixed liquid of 1,4-dioxane and ultrapure water, and the ultrapure water in the mixed liquid accounts for about 1%-20% of the total volume, preferably 5%-10%. After dissolving PLGA and PLA in an organic solvent, add the pearl powder in step (1) according to a certain ratio to make a forming slurry for later use. The PLGA/PLA mixture: pearl powder (mass ratio) is 1:1- 10:1, preferably 2:1-4:1, most preferably 7:3;

在骨修复中,组织细胞的长入、新血管的生成、营养物和代谢物的交换和支架材料的降解都要求支架具有高孔隙率和连通率。支架孔隙率太低,表面积太小,则孔隙之间的贯通性不好,不利于组织的长入;由于与体液的接触面积小,也不利于支架在体内的降解。因此,在保证支架结构的稳定性和要求的力学性能的前提下,支架应具有尽量高的孔隙率和连通率。在步骤(3)中,用3D软件(例如Solidworks)设计具有高孔隙率和连通率的支架模型;根据实际需要,利用3D软件设计任意形状的支架模型,将设计好的CAD模型尺寸储存为STL文件。用Aurora软件打开模型STL文件,对STL文件进行检验和修正后,采用大孔结构单元对其进行三维填充处理,构建含有规则的孔径100~500μm大孔结构,大孔结构的XYZ轴三个方向贯通;对填充后的STL文件进行分层和层片内的填充处理;经检验/修正后转换成可以驱动机构本体子系统的扫描矢量。In bone repair, the growth of tissue cells, the formation of new blood vessels, the exchange of nutrients and metabolites, and the degradation of scaffold materials all require scaffolds with high porosity and connectivity. If the porosity of the scaffold is too low and the surface area is too small, the connectivity between the pores is not good, which is not conducive to the ingrowth of the tissue; due to the small contact area with the body fluid, it is also not conducive to the degradation of the scaffold in the body. Therefore, under the premise of ensuring the stability of the scaffold structure and the required mechanical properties, the scaffold should have as high porosity and connectivity as possible. In step (3), use 3D software (such as Solidworks) to design a bracket model with high porosity and connectivity; according to actual needs, use 3D software to design a bracket model of any shape, and store the designed CAD model size as STL document. Open the model STL file with Aurora software, check and correct the STL file, and use the macroporous structure unit to perform three-dimensional filling processing on it to construct a macroporous structure with a regular pore diameter of 100-500 μm, and the XYZ axis of the macroporous structure in three directions Penetration; layering and filling processing within the ply is performed on the filled STL file; after inspection/correction, it is converted into a scan vector that can drive the subsystem of the mechanism body.

在殷华公司快速成型系统的基础上,加装低温成型室和温控系统。将分层信息文件输入Cark成形控制软件中,自动生成坐标路径等信息;运动控制卡控制X、Y、Z三个方向的步进电机驱动系统,控制生物材料成型喷头成型位置,增压喷头在驱动单元控制下,稳定的挤出成形浆料。在低温成形室内,浆料的迅速降温,浆料中均匀的聚酯溶液发生固—液相分离/液—液相分离,生成溶剂结晶和富聚酯相,然后在更低的温度下分离的两相均凝固成固体。从低温成形室中取出的冷冻支架,被直接放入冷冻干燥机中去除溶剂和支撑材料。在冷冻干燥机中的真空环境中,冷冻支架中的溶剂发生升华,得到具有微孔结构的支架。支架的这种微孔结构直接取决于相分离过程中形成的两相结构,溶剂结晶相相形成孔隙,富聚酯相形成孔壁,珍珠粉末弥散分布在孔壁中。On the basis of Yinhua's rapid prototyping system, a low-temperature molding room and temperature control system are added. Input the hierarchical information file into the Cark forming control software to automatically generate information such as coordinate paths; the motion control card controls the stepping motor drive system in the three directions of X, Y, and Z, and controls the forming position of the biomaterial forming nozzle. Under the control of the driving unit, the slurry is extruded stably. In the low-temperature forming chamber, the rapid cooling of the slurry, the homogeneous polyester solution in the slurry undergoes solid-liquid phase separation/liquid-liquid phase separation, and generates solvent crystallization and polyester-rich phases, which are then separated at lower temperatures Both phases solidify into solids. Cryostents removed from the cryogenic forming chamber are placed directly into a freeze dryer to remove solvent and support material. In the vacuum environment in the freeze dryer, the solvent in the cryo-stent is sublimated to obtain a scaffold with a microporous structure. The microporous structure of the scaffold directly depends on the two-phase structure formed during the phase separation process, the solvent crystalline phase forms the pores, the polyester-rich phase forms the pore walls, and the pearl powder is dispersedly distributed in the pore walls.

根据上述方法制备的人工骨生物支架材料,其宏观结构为具有100-500μm孔径通道,微结构为具有10-20μm微孔的三维支架结构,其中微孔壁弥散分布着微米级珍珠粉,珍珠粉具有100nm级别的规则片层间隙和圆形孔洞结构。支架孔隙率为60%-90%,大孔结构的X、Y、Z轴三个方向贯通,具有100%的贯通率;该人工骨生物支架材料为成骨细胞提供生长的三维空间和足够的内外表面积,有利于细胞悬液浸入和黏附,获得足够营养物质,进行气体交换,排出代谢产物,使细胞按预制形态的三维空间生长,最终形成骨组织。According to the artificial bone bio-scaffold material prepared by the above method, its macrostructure is a channel with an aperture of 100-500 μm, and its microstructure is a three-dimensional scaffold structure with micropores of 10-20 μm, wherein the micropore wall is dispersed with micron pearl powder, pearl powder With 100nm-level regular lamellar gap and circular hole structure. The porosity of the scaffold is 60%-90%, and the X, Y, and Z axes of the macroporous structure penetrate through three directions, with a penetration rate of 100%; the artificial bone bioscaffold material provides osteoblasts with three-dimensional space for growth and sufficient The internal and external areas are conducive to the immersion and adhesion of the cell suspension, obtaining sufficient nutrients, performing gas exchange, and discharging metabolites, so that the cells grow in the three-dimensional space of the prefabricated shape, and finally form bone tissue.

本发明以PLGA/PLA材料作为基体复合珍珠粉的复合材料和以低温快速成型技术获得的支架结构,具有以下主要优点:The present invention uses PLGA/PLA material as the composite material of matrix composite pearl powder and the support structure obtained with low temperature rapid prototyping technology, has the following main advantages:

1.珍珠粉具有良好的生物相容性、诱导性,珍珠粉降解时产生的钙离子可以为新生骨组织所利用,促进骨组织的再生;珍珠层中的蛋白可刺激成骨细胞分化和增殖,激活成骨细胞活性、参与碳酸钙结晶的形成;经特殊的部分脱蛋白处理后珍珠粉的生物相容性进一步提高,具有骨诱导活性的活性因子得到保留。完全脱蛋白的珍珠粉,则保留100nm级别的规则片层间隙和圆形孔洞结构,有助于营养物质扩散、骨细胞增殖和骨的生成。1. Pearl powder has good biocompatibility and inductivity. Calcium ions generated during the degradation of pearl powder can be used by new bone tissue to promote bone tissue regeneration; the protein in the pearl layer can stimulate osteoblast differentiation and proliferation , activate osteoblast activity and participate in the formation of calcium carbonate crystals; after special partial deproteinization treatment, the biocompatibility of pearl powder is further improved, and the active factors with osteoinductive activity are retained. Completely deproteinized pearl powder retains 100nm-level regular lamellar gaps and circular hole structures, which are conducive to the diffusion of nutrients, bone cell proliferation and bone formation.

2.加入PLGA/PLA充当珍珠粉的粘接剂,使材料的加工成形更为方便,采用低温快速成型技术,避了其它剧烈的方法导致珍珠粉诱导骨活性丧失,珍珠粉内规则纳米结构的破坏。构建的支架孔隙率为60%-90%。支架整体结构完成设计要求,支架具有规则的大孔结构和通道,大孔结构的X、Y、Z轴三个方向贯通,具有100%的贯通率;2. Adding PLGA/PLA as the binder of pearl powder makes the processing and forming of the material more convenient. The low-temperature rapid prototyping technology is used to avoid the loss of bone activity induced by pearl powder caused by other drastic methods, and the regular nanostructure in the pearl powder destroy. The porosity of the constructed scaffold is 60%-90%. The overall structure of the bracket meets the design requirements. The bracket has a regular large-hole structure and channels, and the X, Y, and Z axes of the large-hole structure are penetrated in three directions, with a 100% penetration rate;

3.提供足够的机械性能是一个支架的关键要求,如果支架不能提供在一系列坚硬组织(10-1500MPA)或软组织(0.4-350MPA)的机械模量,那么任何一个新生组织的成形也可能会过度变形而失败。本发明制造的支架结构,的测量值分别为压缩弹性模量17.83±1.73MPa-25.62±2.35MPa和抗压强度0.67±0.07MPa-1.47±0.11MPa,复合材料拥有比单一的PLGA/PLA更高的强度以及比单一的珍珠粉更好的韧性,综合力学性能得到了优化。3. Providing sufficient mechanical properties is a key requirement for a scaffold. If the scaffold cannot provide a mechanical modulus in a range of hard tissues (10-1500MPA) or soft tissues (0.4-350MPA), then the formation of any new tissue may also be difficult. Fails due to excessive deformation. The measured values of the stent structure manufactured by the present invention are respectively compressive elastic modulus 17.83±1.73MPa-25.62±2.35MPa and compressive strength 0.67±0.07MPa-1.47±0.11MPa, and the composite material has higher The strength and toughness are better than single pearl powder, and the comprehensive mechanical properties have been optimized.

4.分级结构的设计,满足了骨生长的空间条件,大孔结构规则圆润,孔径100~500μm有助于诱导血管和含有哈佛氏系统的成熟骨长入,大孔的孔壁中布满孔径100μm以下圆润的微孔结构有助于细胞团生长、以及复合弥散分布的珍珠粉和其他生长因子并实现可控缓释;微孔的孔壁厚度为1-10μm,珍珠粉100nm级别的规则片层间隙和圆形孔洞结构,有助于营养物质扩散、成骨细胞增殖和骨的生成,可增加支架的骨诱导活性4. The design of the hierarchical structure satisfies the spatial conditions for bone growth. The macropore structure is regular and round, and the pore size is 100-500 μm, which is helpful for inducing the growth of blood vessels and mature bone containing Haversian system. The pore wall of the macropore is full of pores with a diameter below 100 μm. The rounded microporous structure is helpful for the growth of cell clusters, as well as the complex and diffuse distribution of pearl powder and other growth factors to achieve controllable slow release; the thickness of the micropore wall is 1-10μm, and the regular lamellar gap of pearl powder is 100nm And the circular hole structure, which helps the diffusion of nutrients, the proliferation of osteoblasts and the formation of bone, can increase the osteoinductive activity of the scaffold

下面结合具体实施方式对本发明作进一步说明,本发明的保护范围并不局限于实施例,凡是根据本发明公开的内容或原理实施的任何本领域的等同替换,均属于本发明的保护范围。The present invention will be further described below in conjunction with specific embodiments. The protection scope of the present invention is not limited to the embodiments. Any equivalent replacement in the field implemented according to the disclosed content or principles of the present invention belongs to the protection scope of the present invention.

附图说明 Description of drawings

图1为低温快速成型装置结构和喷头成型过程图,在殷华公司快速成型系统的基础上,加装低温成型室和温控系统。成形室的空间大小为300mm(X方向)×320mm(Y方向)×700mm(Z方向),顶部敞开,制冷装置分布在成形室的一侧,另一侧有可以打开的操作门,最低的制冷温度为-40℃,恒温能力为±2℃。其中,图1中(1)为Y轴滑块,(2)为X轴滑块,(3)为储料罐,(4)为Z轴滑块,(5)为喷头固定架,(6)为送料软管,(7)为隔热软膜,(8)为低温成型室,(9)为喷头,(10)为已成型支架,(11)为工作台。Figure 1 is a diagram of the structure of the low-temperature rapid prototyping device and the nozzle forming process. On the basis of the rapid prototyping system of Yinhua Company, a low-temperature prototyping chamber and a temperature control system are added. The space size of the forming room is 300mm (X direction) × 320mm (Y direction) × 700mm (Z direction), the top is open, the cooling device is distributed on one side of the forming room, and the other side has an openable operation door, the lowest refrigeration The temperature is -40°C, and the constant temperature capability is ±2°C. Among them, in Figure 1 (1) is the Y-axis slider, (2) is the X-axis slider, (3) is the storage tank, (4) is the Z-axis slider, (5) is the nozzle holder, (6) ) is a feeding hose, (7) is a heat-insulating soft film, (8) is a low-temperature molding chamber, (9) is a nozzle, (10) is a formed bracket, and (11) is a workbench.

图2为三维支架多级结构图,其中2-A为整体结构;2-B为横截面大孔阵列结构;2-C为大孔结构(电子显微镜);2-D为微孔结构(电子显微镜)。Fig. 2 is three-dimensional scaffold multilevel structure figure, wherein 2-A is overall structure; 2-B is cross-sectional macropore array structure; 2-C is macroporous structure (electron microscope); 2-D is microporous structure (electron microscope) microscope).

图3为PLGA/PLA、珍珠粉复合材料支架和新西兰白兔骨髓间充质干细胞共培养10天后的电子显微镜图,显示MSC细胞在支架内大量增殖。Figure 3 is an electron microscope image of PLGA/PLA, pearl powder composite material scaffold and New Zealand white rabbit bone marrow mesenchymal stem cells co-cultured for 10 days, showing that MSC cells proliferated in a large number in the scaffold.

附图4为PLGA/PLA、珍珠粉复合材料支架和新西兰白兔骨髓间充质干细胞共培养10天,抗I型胶原蛋白抗体免疫组织化鉴定图,图片背景为绿色。Accompanying drawing 4 is PLGA/PLA, pearl powder composite scaffold and New Zealand white rabbit bone marrow mesenchymal stem cells co-cultured for 10 days, the immunohistochemical identification picture of anti-type I collagen antibody, the background of the picture is green.

附图5为PLGA/PLA、珍珠粉复合材料支架和新西兰白兔骨髓间充质干细胞共培养培养21天,天茜素红染色诱导生成的钙结节图,图中背景为黑色,斑点为红色钙结节。Figure 5 is a picture of calcium nodules induced by alizarin red staining after 21 days of co-culture with PLGA/PLA, pearl powder composite scaffolds and New Zealand white rabbit bone marrow mesenchymal stem cells. The background in the figure is black and the spots are red calcium nodules.

具体实施方式 Detailed ways

实施例1Example 1

取珍珠粉(浙江山下湖珍珠集团),用振动筛对其进行-2000目和+3000目的筛分以获得直径在1μm-10μm的珍珠粉,随后对珍珠粉用1:1氯仿/甲醇脱脂12h;37℃ PBS+NaOH+NaN3混合液浸泡12h后三蒸水漂洗;37℃ 200g/L H2O2浸泡6h以部分脱蛋白;三蒸水反复漂洗6次,放入37℃恒温干燥箱中干燥;密封包装,钴60消毒备用。Take pearl powder (Zhejiang Shanxia Lake Pearl Group), and use a vibrating sieve to sieve it with -2000 mesh and +3000 mesh to obtain pearl powder with a diameter of 1 μm-10 μm, and then degrease the pearl powder with 1:1 chloroform/methanol for 12 hours ;Soak in PBS+NaOH+NaN3 mixture at 37°C for 12h, then rinse with triple-distilled water; soak in 200g/L H 2 O 2 at 37°C for 6h to partially deproteinize; rinse with triple-distilled water for 6 times, and dry in a 37°C constant temperature drying oven ; Sealed packaging, cobalt 60 disinfection for use.

PLGA/PLA(3:1)按照15%(w/v)的浓度溶解于1,4-二氧六环(上海化学试剂采购供应五联化工厂,分析纯)有机溶剂,40℃搅拌溶解,构成的液—液相分离体系的浊点为28℃;按照PLGA/PLA:珍珠粉=70/30(w/w)的比例加入珍珠粉末后制备成形浆料;30℃常温保存备用。PLGA/PLA (3:1) was dissolved in 1,4-dioxane (Shanghai Chemical Reagent Purchase and Supply Wulian Chemical Factory, analytically pure) organic solvent according to the concentration of 15% (w/v), stirred and dissolved at 40°C, The cloud point of the formed liquid-liquid phase separation system is 28°C; add pearl powder according to the ratio of PLGA/PLA: pearl powder=70/30 (w/w) to prepare a forming slurry; store at room temperature at 30°C for future use.

用3D软件Solidworks构建设计好的三维结构,CAD模型尺寸:2×2×2cm3,用Aurora软件打开3D支架模型STL文件,对STL文件进行检验和修正后,采用大孔结构单元对其进行三维填充处理,构建含有规则的孔径200μm大孔结构,大孔结构的XYZ轴三个方向贯通;对填充后的STL文件进行分层和层片内的填充处理,生成层片文件(SLI,CLI)和网格文件(NET)网格宽度:d=1mm;经检验/修正后转换成可以驱动机构本体子系统的扫描矢量驱动设备成型(殷华公司快速成型系统,图1)。低温成型室温度为-30℃;喷头转速控制频率为200Hz;扫描速度为6mm/s。Use the 3D software Solidworks to build the designed 3D structure, the CAD model size: 2×2×2cm 3 , use the Aurora software to open the 3D support model STL file, after checking and correcting the STL file, use the macroporous structural unit to make a 3D analysis of it Filling processing, constructing a macroporous structure with a regular pore diameter of 200 μm, and the XYZ axes of the macroporous structure run through in three directions; perform layering and filling processing in the filled STL file to generate a layered file (SLI, CLI) And grid file (NET) grid width: d=1mm; After inspection/correction, it is converted into a scanning vector-driven equipment molding that can drive the body subsystem of the mechanism (Yinhua company's rapid prototyping system, Figure 1). The temperature of the low-temperature molding chamber is -30°C; the speed control frequency of the nozzle is 200Hz; the scanning speed is 6mm/s.

在低温成形室内,浆料的迅速降温,浆料中均匀的聚酯溶液发生固—液相分离/液—液相分离,生成溶剂结晶和富聚酯相,然后在更低的温度下分离的两相均凝固成固体。从低温成形室中取出的冷冻支架,被直接放入冷冻干燥机中去除溶剂和支撑材料(-40℃)。在冷冻干燥机中的真空环境中,冷冻支架中的溶剂发生升华,得到具有微孔结构的支架(图2-A,图2-B)。支架的这种微孔结构直接取决于相分离过程中形成的两相结构,溶剂结晶相相形成孔隙,富聚酯相形成孔壁,珍珠粉末弥散分布在孔壁中。支架的宏观结构具有100-500μm孔径通道(图2-C),微结构为具有10-20μm微孔(图2-D)的三维支架结构,其中微孔壁弥散分布着微米级珍珠粉。孔隙率为79%,大孔结构的X、Y、Z轴三个方向贯通,具有100%的贯通率;支架压缩弹性模量18.71±1.61MPa和抗压强度0.92±0.06MPa。In the low-temperature forming chamber, the rapid cooling of the slurry, the homogeneous polyester solution in the slurry undergoes solid-liquid phase separation/liquid-liquid phase separation, and generates solvent crystallization and polyester-rich phases, which are then separated at lower temperatures Both phases solidify into solids. Cryostents removed from the cryogenic forming chamber were placed directly into a freeze dryer to remove solvent and support material (-40°C). In the vacuum environment in the freeze dryer, the solvent in the cryo-stent sublimates to obtain a scaffold with a microporous structure (Fig. 2-A, Fig. 2-B). The microporous structure of the scaffold directly depends on the two-phase structure formed during the phase separation process, the solvent crystalline phase forms the pores, the polyester-rich phase forms the pore walls, and the pearl powder is dispersedly distributed in the pore walls. The macrostructure of the scaffold has a 100-500 μm pore diameter channel (Figure 2-C), and the microstructure is a three-dimensional scaffold structure with 10-20 μm micropores (Figure 2-D), in which the micropore walls are dispersed with micron-sized pearl powder. The porosity is 79%, and the X, Y, and Z axes of the macroporous structure are penetrated in three directions, with a penetration rate of 100%; the compressive elastic modulus of the bracket is 18.71±1.61MPa and the compressive strength is 0.92±0.06MPa.

实施例2Example 2

取珍珠粉(浙江山下湖珍珠集团),振动筛对其进行2000目的筛分以获得直径在3-6μm的珍珠粉,随后对珍珠粉用1:1氯仿/甲醇脱脂12h;37℃ PBS+NaOH+NaN3混合液浸泡12h后三蒸水漂洗;37℃200g/L H2O2浸泡24h以完全脱蛋白;三蒸水反复漂洗6次,放入37℃恒温干燥箱中干燥;密封包装,Co60照射消毒备用。Take pearl powder (Zhejiang Shanxia Lake Pearl Group), and sieve it with a 2000-mesh vibrating sieve to obtain pearl powder with a diameter of 3-6 μm, then degrease the pearl powder with 1:1 chloroform/methanol for 12 hours; 37 ° C PBS+NaOH Soak in +NaN3 mixed solution for 12 hours, then rinse with triple distilled water; soak in 200g/L H 2 O 2 at 37°C for 24 hours to completely deproteinize; rinse with triple distilled water for 6 times, and dry in a constant temperature drying oven at 37°C; seal the package, and irradiate with Co60 Disinfect and set aside.

配置1,4-二氧六环(上海化学试剂采购供应五联化工厂,分析纯)和水的混合液,其中混合液中水的含量为5%(V/V)。PLGA/PLA(4:1)按照15%(w/v)的浓度溶解于混合液,40℃搅拌溶解;按照(PLGA+PLA)/珍珠粉=65/35(w/w)的比例加入珍珠粉末后制备成形浆料;30℃常温保存备用。Prepare a mixed solution of 1,4-dioxane (purchased and supplied by Shanghai Chemical Reagent Wulian Chemical Plant, analytically pure) and water, wherein the water content in the mixed solution is 5% (V water /V total ). PLGA/PLA (4:1) was dissolved in the mixed liquid at a concentration of 15% (w/v), stirred and dissolved at 40°C; pearls were added according to the ratio of (PLGA+PLA)/pearl powder=65/35 (w/w) Prepare the forming slurry after powdering; store at room temperature at 30°C for later use.

3D软件Solidworks构建设计好的三维结构,CAD模型尺寸:1.5×1.5×5cm3,用Aurora软件打开3D支架模型STL文件,对STL文件进行检验和修正后,采用大孔结构单元对其进行三维填充处理,构建含有规则的孔径200μm大孔结构,大孔结构的XYZ轴三个方向贯通;对填充后的STL文件进行分层和层片内的填充处理,生成层片文件(SLI,CLI)和网格文件(NET)网格宽度:d=0.5mm;经检验/修正后转换成可以驱动机构本体子系统的扫描矢量驱动设备成型。成型室温度为-30℃;喷头转速控制频率为250Hz;扫描速度为5mm/s。3D software Solidworks builds the designed 3D structure, CAD model size: 1.5×1.5×5cm 3 , opens the 3D support model STL file with Aurora software, checks and corrects the STL file, and uses macroporous structural elements to fill it in 3D Processing, constructing a macroporous structure with a regular pore diameter of 200 μm, and the XYZ axes of the macroporous structure penetrate in three directions; perform layering and filling processing on the filled STL file to generate a layer file (SLI, CLI) and Grid file (NET) grid width: d=0.5mm; after inspection/correction, it is transformed into a scan vector drive device that can drive the body subsystem of the mechanism. The temperature of the molding chamber is -30°C; the speed control frequency of the nozzle is 250Hz; the scanning speed is 5mm/s.

在低温成形室内,浆料的迅速降温发生固—液相分离/液—液相分离,生成溶剂结晶和富聚酯相,然后在更低的温度下分离的两相均凝固成固体。从低温成形室中取出的冷冻支架,先放入液氮中保存10min,然后放入冷冻干燥机中去除溶剂和支撑材料(-40℃)。在冷冻干燥机中的真空环境中,冷冻支架中的溶剂发生升华,得到具有微孔结构的支架。支架的宏观结构具有100μm孔径通道,微结构为具有10-20μm微孔的三维支架结构,其中微孔壁弥散分布着微米级珍珠粉。孔隙率为85%,大孔结构的X、Y、Z轴三个方向贯通,具有100%的贯通率;支架压缩弹性模量19.88±1.87MPa和抗压强度0.98±0.08MPa。In the low-temperature forming chamber, solid-liquid phase separation/liquid-liquid phase separation occurs during rapid cooling of the slurry, resulting in solvent crystallization and polyester-rich phases, and then the two phases separated at lower temperatures solidify into solids. The cryo-stents taken out of the low-temperature forming chamber were first stored in liquid nitrogen for 10 min, and then placed in a freeze dryer to remove solvent and support material (-40°C). In the vacuum environment in the freeze dryer, the solvent in the cryo-stent is sublimated to obtain a scaffold with a microporous structure. The macrostructure of the scaffold has a channel with a pore size of 100 μm, and the microstructure is a three-dimensional scaffold structure with micropores of 10-20 μm, in which micron-sized pearl powder is diffusely distributed on the walls of the micropores. The porosity is 85%, and the X, Y, and Z axes of the macroporous structure are penetrated in three directions, with a penetration rate of 100%; the compressive elastic modulus of the bracket is 19.88±1.87MPa and the compressive strength is 0.98±0.08MPa.

实施例3Example 3

取实施例1制备的复合材料支架和新西兰白兔骨髓间充质干细胞(MSCs),共培养于三维细胞/组织培养系统(RCCSTM,NASA),培养10天后,戊二醛4℃固定,以乙酸4℃后固定1h后,醋酸铀-枸橼酸铅双重染色,扫描电子显微镜观察结构(图3)。显示细胞在三维支架结构内生长、增殖、迁移良好,细胞在三维空间内按照一定的方向伸展,并在孔隙内形成网状结构,并留下营养物质通过的通道。Take the composite material scaffold prepared in Example 1 and New Zealand white rabbit bone marrow mesenchymal stem cells (MSCs), and co-culture them in a three-dimensional cell/tissue culture system (RCCS , NASA). After culturing for 10 days, fix with glutaraldehyde at 4°C, and After fixation in acetic acid at 4°C for 1 h, double staining with uranyl acetate-lead citrate, the structure was observed with a scanning electron microscope (Figure 3). It shows that the cells grow, proliferate, and migrate well in the three-dimensional scaffold structure. The cells stretch in a certain direction in the three-dimensional space, and form a network structure in the pores, leaving channels for nutrients to pass through.

实施例4Example 4

取实施例1制备的复合材料支架和新西兰白兔骨髓间充质干细胞(MSCs),共培养于三维细胞/组织培养系统(RCCSTM NASA),培养10天后,取出支架,10%中性福尔马林溶液固定30分钟,用FITC标记的抗I型胶原蛋白抗体进行免疫组织化鉴定,荧光显微镜观察(图4),可见90%以上的细胞和结构体表达绿色荧光。I型胶原约占骨组织有机物含量的90%,研究证明支架内MSC细胞大量分化为成骨细胞,合成骨骼的重要成分。Take the composite material scaffold prepared in Example 1 and New Zealand white rabbit bone marrow mesenchymal stem cells (MSCs), and co-culture them in a three-dimensional cell/tissue culture system (RCCS TM NASA). Marin solution was fixed for 30 minutes, immunohistochemical identification was carried out with FITC-labeled anti-type I collagen antibody, and fluorescence microscope observation (Figure 4) showed that more than 90% of the cells and structures expressed green fluorescence. Type I collagen accounts for about 90% of the organic content of bone tissue. Studies have shown that MSC cells in the scaffold differentiate into osteoblasts and synthesize important components of bone.

实施例5Example 5

取实施例1制备的复合材料支架和新西兰白兔骨髓间充质干细胞(MSCs),共培养于三维细胞/组织培养系统(RCCSTM NASA),培养21天后,取出支架,4%多聚甲醛固定30分钟,天茜素红染色诱导生成的钙结节,可见支架内在细胞聚集的部位出现大量红色钙结节,支架呈现显著的骨诱导活性(图5)。Take the composite material scaffold prepared in Example 1 and New Zealand White Rabbit Bone Marrow Mesenchymal Stem Cells (MSCs), and co-culture them in a three-dimensional cell/tissue culture system (RCCS NASA). After culturing for 21 days, take out the scaffold and fix with 4% paraformaldehyde After 30 minutes, the induced calcium nodules were stained with alizarin red, and a large number of red calcium nodules appeared at the site of cell aggregation in the scaffold, and the scaffold showed significant osteoinductive activity (Fig. 5).

Claims (10)

1, a kind of compositions that contains PLGA, PLA and Margarita powder is characterized in that: PLGA:PLA in the described compositions (mass ratio) is 1:1-10:1; The PLGA/PLA mixture: Margarita powder (mass ratio) is 1:1-10:1, and described Margarita powder diameter is the 1-10 micron.
2, compositions according to claim 1 is characterized in that: Margarita powder is part deproteinization or complete Deproteinated Margarita powder in the described compositions.
3, the artificial bone biologic bracket material of preparation of compositions according to claim 1 is characterized in that: described timbering material is that macrostructure has 100-500 μ m aperture passage, and micro structure is the three-dimensional rack structure with 10-20 μ m micropore.
4, according to according to right 3 described artificial bone biologic bracket materials, it is characterized in that: the porosity of described timbering material is 60%-90%.
5, according to according to right 3 described artificial bone biologic bracket materials, it is characterized in that: the X of the macroporous structure of described timbering material, Y, three directions of Z axle connect, and have 100% perforation rate.
6, according to according to right 3 described artificial bone biologic bracket materials, it is characterized in that: the modulus of elasticity in comperssion of described timbering material is 17.83 ± 1.73MPa-25.62 ± 2.35MPa.
7, according to according to right 3 described artificial bone biologic bracket materials, it is characterized in that: the comprcssive strength 0.67 ± 0.07MPa-1.47 ± 0.11MPa of described timbering material.
8, a kind of method for preparing artificial bone biologic bracket material as claimed in claim 3 comprises the steps:
(1) antigen Margarita powder or complete Deproteinization Margarita powder are removed in preparation;
(2) preparation contains the slurry of PLGA, PLA and Margarita powder;
(3) has the three-dimensional rack of high porosity and connection rate by the 3D software design;
(4) utilize the low temperature rapid prototyping system to make the three-dimensional rack molding.
9, method according to claim 8, it is characterized in that: the process of step (2) is for being that PLGA and the PLA of 1:1-10:1 is dissolved in the organic solvent with mass ratio, described organic solvent is selected from chloroform, dimethyl sulfoxide, 1,4-dioxane or 1, the mixing material of 4-dioxane and ultra-pure water, then according to the PLGA/PLA mixture: Margarita powder (mass ratio) is made the shaping slurry for the Margarita powder in the ratio adding step (1) of 1:1-6:1.
10, method according to claim 8 is characterized in that: the low temperature rapid prototyping system described in the step (4) installs low temperature moulding chamber and temperature control system additional on the basis of Yin Hua company rapid prototyping system.
CN2009100963338A 2009-02-20 2009-02-20 Pearl powder artificial bone supporting material with multi-stage micro-nano structure and technique for producing the same Active CN101496908B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009100963338A CN101496908B (en) 2009-02-20 2009-02-20 Pearl powder artificial bone supporting material with multi-stage micro-nano structure and technique for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009100963338A CN101496908B (en) 2009-02-20 2009-02-20 Pearl powder artificial bone supporting material with multi-stage micro-nano structure and technique for producing the same

Publications (2)

Publication Number Publication Date
CN101496908A true CN101496908A (en) 2009-08-05
CN101496908B CN101496908B (en) 2012-10-31

Family

ID=40944317

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009100963338A Active CN101496908B (en) 2009-02-20 2009-02-20 Pearl powder artificial bone supporting material with multi-stage micro-nano structure and technique for producing the same

Country Status (1)

Country Link
CN (1) CN101496908B (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101856515A (en) * 2010-06-04 2010-10-13 西南大学 Method for preparing artificial bone from chitosan and shell powder
CN102357262A (en) * 2011-10-09 2012-02-22 清华大学 Porous composite scaffold of PLLA (polylactic acid)/pearl powder and its preparation method
CN102416198A (en) * 2011-12-02 2012-04-18 清华大学 Preparation method of pearl active substance extract/hydroxyapatite bone repair material
CN102512266A (en) * 2012-01-16 2012-06-27 杭州电子科技大学 Method for preparing spinal cord injury repair tissue engineering stent
CN102784014A (en) * 2012-08-14 2012-11-21 中国科学院深圳先进技术研究院 Porotic bone scaffold and preparation method thereof
CN102949753A (en) * 2012-11-26 2013-03-06 中国人民解放军第四军医大学 Porous composite bracket and preparation method thereof
CN103480045A (en) * 2013-09-10 2014-01-01 黄晚兰 Fully degradable high molecular material cardiovascular stent
CN105727368A (en) * 2016-01-08 2016-07-06 深圳市第二人民医院 Three-dimensional composite material support and preparation method thereof
CN106132449A (en) * 2014-01-10 2016-11-16 Mbp(毛里求斯)有限公司 For the method producing bone engagement device, the bone engagement device being made up of the semi-synthetic composite being obtained by the component of structural change natural marine organism material and implant
CN107041971A (en) * 2016-09-19 2017-08-15 盐城工业职业技术学院 A kind of fibroin based on 3 D-printing/gelatin timbering material and preparation method thereof
CN107185048A (en) * 2017-06-28 2017-09-22 海口市人民医院 The preparation method of Nano pearl powder/C HA compound rests
CN107261215A (en) * 2017-06-28 2017-10-20 海口市人民医院 Nano pearl powder/C HA compound rests and its application
CN108904103A (en) * 2018-05-30 2018-11-30 中国科学院深圳先进技术研究院 A kind of method and apparatus preparing heterogeneous bone renovating material
CN113858610A (en) * 2021-09-06 2021-12-31 江苏卓见医疗用品有限公司 Medical fibrous surface dressing and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1117587C (en) * 2000-04-14 2003-08-13 清华大学 Manufacture of porous holder for repairing tissue and organ
CN1169497C (en) * 2001-03-14 2004-10-06 陈建庭 Composite artificial bone and its making process
CN1176726C (en) * 2002-07-10 2004-11-24 浙江大学 Preparation method of polylactic acid porous scaffold for tissue engineering

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101856515B (en) * 2010-06-04 2013-03-13 西南大学 Method for preparing artificial bone from chitosan and shell powder serving as raw materials
CN101856515A (en) * 2010-06-04 2010-10-13 西南大学 Method for preparing artificial bone from chitosan and shell powder
CN102357262A (en) * 2011-10-09 2012-02-22 清华大学 Porous composite scaffold of PLLA (polylactic acid)/pearl powder and its preparation method
CN102416198A (en) * 2011-12-02 2012-04-18 清华大学 Preparation method of pearl active substance extract/hydroxyapatite bone repair material
CN102512266A (en) * 2012-01-16 2012-06-27 杭州电子科技大学 Method for preparing spinal cord injury repair tissue engineering stent
CN102512266B (en) * 2012-01-16 2015-04-29 杭州电子科技大学 Method for preparing spinal cord injury repair tissue engineering stent
CN102784014B (en) * 2012-08-14 2014-11-26 中国科学院深圳先进技术研究院 Porotic bone scaffold and preparation method thereof
CN102784014A (en) * 2012-08-14 2012-11-21 中国科学院深圳先进技术研究院 Porotic bone scaffold and preparation method thereof
CN102949753A (en) * 2012-11-26 2013-03-06 中国人民解放军第四军医大学 Porous composite bracket and preparation method thereof
CN103480045A (en) * 2013-09-10 2014-01-01 黄晚兰 Fully degradable high molecular material cardiovascular stent
CN103480045B (en) * 2013-09-10 2015-09-16 黄晚兰 Fully-degradable polymer material cardiovascular stent
CN106132449A (en) * 2014-01-10 2016-11-16 Mbp(毛里求斯)有限公司 For the method producing bone engagement device, the bone engagement device being made up of the semi-synthetic composite being obtained by the component of structural change natural marine organism material and implant
CN105727368A (en) * 2016-01-08 2016-07-06 深圳市第二人民医院 Three-dimensional composite material support and preparation method thereof
CN107041971A (en) * 2016-09-19 2017-08-15 盐城工业职业技术学院 A kind of fibroin based on 3 D-printing/gelatin timbering material and preparation method thereof
CN107185048A (en) * 2017-06-28 2017-09-22 海口市人民医院 The preparation method of Nano pearl powder/C HA compound rests
CN107261215A (en) * 2017-06-28 2017-10-20 海口市人民医院 Nano pearl powder/C HA compound rests and its application
CN108904103A (en) * 2018-05-30 2018-11-30 中国科学院深圳先进技术研究院 A kind of method and apparatus preparing heterogeneous bone renovating material
CN113858610A (en) * 2021-09-06 2021-12-31 江苏卓见医疗用品有限公司 Medical fibrous surface dressing and preparation method and application thereof
CN113858610B (en) * 2021-09-06 2024-04-19 江苏卓见医疗用品有限公司 Medical fibrous surface dressing and preparation method and application thereof

Also Published As

Publication number Publication date
CN101496908B (en) 2012-10-31

Similar Documents

Publication Publication Date Title
CN101496908B (en) Pearl powder artificial bone supporting material with multi-stage micro-nano structure and technique for producing the same
Hu et al. Preparation and cell affinity of microtubular orientation-structured PLGA (70/30) blood vessel scaffold
Geetha Bai et al. Graphene-based 3D scaffolds in tissue engineering: fabrication, applications, and future scope in liver tissue engineering
Holzwarth et al. Biomimetic nanofibrous scaffolds for bone tissue engineering
CN105031718B (en) Porous composite scaffold for bone repair based on 3D-Bioplotter printing technology and its preparation method
Li et al. Recent progress in tissue engineering and regenerative medicine
Wang et al. Polylactic acid scaffold with directional porous structure for large-segment bone repair
CN101147810B (en) Cell-biodegradable material composite and its preparation method and application
CN104001208B (en) Preparation method for biomacromolecule/chitin nanocrystalline composite scaffold material
Qi et al. 3D-printed porous functional composite scaffolds with polydopamine decoration for bone regeneration
CN101264341A (en) Three-dimensional porous tissue engineering scaffold material, its preparation and application
CN102499997A (en) Composite nano fiber support material, as well as preparation method and application in bone repairing aspect
Chanes-Cuevas et al. Macro-, micro-and mesoporous materials for tissue engineering applications.
US9629939B2 (en) Collagenous foam materials
CN102580145B (en) Method for preparing phosphomycin calcium/hexagonal mesoporous silicon/poly glycolide-co-lactide (PLGA) bone tissue stent
Wang et al. Physical properties and biocompatibility of a core‐sheath structure composite scaffold for bone tissue engineering in vitro
CN106039400B (en) Preparation method and application of three-dimensional bioscaffold with regular lamellar structure by ice crystal template method
CN103602844A (en) Preparation method of porous biomedical metal, ceramic or metal/ceramic composite material
Saptaji et al. Review of the Potential use of Poly (lactic-co-glycolic acid) as Scaffolds in Bone Tissue Recovery
Chen et al. Preparation of polymer-based porous scaffolds for tissue engineering
CN102580162A (en) Method for preparing hydroxyapatite/poly glycolide-co-lactide (PLGA)/chitosan three-dimensional porous stent
Li et al. Radially porous nonmulberry silk fibroin nanofiber scaffolds for bone repair
Kang et al. Integrating Top‐Down and Bottom‐Up Scaffolding Tissue Engineering Approach for Bone Regeneration
Tan et al. Research on the osteogenesis and biosafety of ECM–Loaded 3D–Printed Gel/SA/58sBG scaffolds
WO2001082987A1 (en) A preparation method for a porous framework used in the prostheses of tissue and organs

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: HANGZHOU JIENUOFEI BIOTECHNOLOGY CO., LTD.

Free format text: FORMER OWNER: HANGZHOU ELECTRONIC SCIENCE AND TECHNOLOGY UNIV

Effective date: 20130717

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 310018 HANGZHOU, ZHEJIANG PROVINCE TO: 311202 HANGZHOU, ZHEJIANG PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20130717

Address after: Hangzhou City, Zhejiang province Xiaoshan District 311202 North Street five Hing Road No. 237

Patentee after: Hangzhou Jienuofei Biotechnology Co., Ltd.

Address before: Hangzhou City, Zhejiang province 310018 Jianggan District Xiasha Higher Education Park No. 2 street

Patentee before: Hangzhou Electronic Science and Technology Univ

CP01 Change in the name or title of a patent holder

Address after: Hangzhou City, Zhejiang province Xiaoshan District 311202 North Street five Hing Road No. 237

Patentee after: Hangzhou giantlok fly biological Polytron Technologies Inc

Address before: Hangzhou City, Zhejiang province Xiaoshan District 311202 North Street five Hing Road No. 237

Patentee before: Hangzhou Jienuofei Biotechnology Co., Ltd.

CP01 Change in the name or title of a patent holder